Globus Medical Inc
NYSE:GMED

Watchlist Manager
Globus Medical Inc Logo
Globus Medical Inc
NYSE:GMED
Watchlist
Price: 90.16 USD -1.7% Market Closed
Market Cap: 12.2B USD

Intrinsic Value

The intrinsic value of one GMED stock under the Base Case scenario is hidden USD. Compared to the current market price of 90.16 USD, Globus Medical Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

GMED Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Globus Medical Inc

Intrinsic Value History
Dive into the past to invest in the future

GMED looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether GMED usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about GMED?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is GMED valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Globus Medical Inc.

Explain Valuation
Compare GMED to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Globus Medical’s heavy reliance on the U.S. spine market exposes it to heightened competitive pressures from entrenched orthopedic giants, which may hamper market share and compress pricing if leading rivals broaden their offerings or engage in aggressive discounting.

Bull Theses

Globus Medical’s robust robotics platform, highlighted by the ExcelsiusGPS system, offers a strong differentiator in spine procedures and positions the firm at the forefront of emerging surgical technology trends.

Show More Less
How do you feel about GMED?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Globus Medical Inc

Current Assets 1.9B
Cash & Short-Term Investments 390.5m
Receivables 688.1m
Other Current Assets 845.7m
Non-Current Assets 3.2B
Long-Term Investments 16.7m
PP&E 637.9m
Intangibles 2.2B
Other Non-Current Assets 308.5m
Current Liabilities 466m
Accounts Payable 87.2m
Accrued Liabilities 339.9m
Other Current Liabilities 38.8m
Non-Current Liabilities 230.9m
Long-Term Debt 427k
Other Non-Current Liabilities 230.4m
Efficiency

Free Cash Flow Analysis
Globus Medical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Globus Medical Inc

Revenue
2.8B USD
Cost of Revenue
-912.6m USD
Gross Profit
1.9B USD
Operating Expenses
-1.4B USD
Operating Income
481.1m USD
Other Expenses
-57.3m USD
Net Income
423.8m USD
Fundamental Scores

GMED Profitability Score
Profitability Due Diligence

Globus Medical Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Healthy Operating Margin
Sustainable 3Y Average Operating Margin
hidden
Profitability
Score

Globus Medical Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

GMED Solvency Score
Solvency Due Diligence

Globus Medical Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
hidden
Solvency
Score

Globus Medical Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GMED Price Targets Summary
Globus Medical Inc

Wall Street analysts forecast GMED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GMED is 98.26 USD with a low forecast of 76.76 USD and a high forecast of 119.7 USD.

Lowest
Price Target
76.76 USD
15% Downside
Average
Price Target
98.26 USD
9% Upside
Highest
Price Target
119.7 USD
33% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Globus Medical Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for GMED is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

GMED Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one GMED stock?

The intrinsic value of one GMED stock under the Base Case scenario is hidden USD.

Is GMED stock undervalued or overvalued?

Compared to the current market price of 90.16 USD, Globus Medical Inc is hidden .

Back to Top